Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$3,071,774.00
Jun 1, 2021
For-profit organization
COVID-19 Response (VI): STAGE 2 Oral DNA Vaccine Development
974484
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergent or predicted SARS-CoV-2 variants, as well as the continued evaluation of the lead vaccine candidate in a Phase I clinical trial.
$34,800.00
Jun 1, 2021
For-profit organization
Development of grapevine leafroll-associated virus 3 (GLRaV-3) vaccine
973465
The attenuated grapevine leafroll-associated virus 3 will be developed by mutagenesis and tested for protection of GLRaV-3 free tissue culture against the infection of wild-type GLRaV-3 in the field.
$49,337.00
Jun 1, 2021
For-profit organization
Small molecule drug development for COVID
973631
Using a bioassay guided fractionation method, AffinityImmuno identified a natural product that is a potent inhibitor of SARS-CoV-2 spike protein binding to ACE2. Research on this natural product is to be accelerated and tested in an series of SARS-CoV-2 permissible cell lines and a hamster model of Covid-19 in order to determine whether to pursue a human health product.
$40,000.00
Jun 1, 2021
For-profit organization
COVID19 Immunization Services for Vulnerable Populations
972786
OKAKI is a public health services and health technology social enterprise. has partnered with a number of organizations to deliver COVID19 Immunization services, in a trusted setting, to vulnerable, hard to reach populations with significant barriers to accessing mainstream services and/or a history of systemic racism in the healthcare system.
$42,369.00
Jun 1, 2021
For-profit organization
000021268
000021268
To support business needs while recovering from COVID-19
$42,369.00
Jun 1, 2021
For-profit organization
000021268
000021268
To support business needs while recovering from COVID-19
$60,000.00
Jun 1, 2021
For-profit organization
000021365
000021365
To support business needs while recovering from COVID-19
$60,000.00
Jun 1, 2021
For-profit organization
000021444
000021444
To support business needs while recovering from COVID-19
$60,000.00
Jun 1, 2021
For-profit organization
000021478
000021478
To support business needs while recovering from COVID-19
$60,000.00
Jun 1, 2021
For-profit organization
000019070
000019070
To support business needs while recovering from COVID-19